IL2-dependent phosphorylation of 40S ribosomal protein S6 is controlled by PI-3K/mTOR signalling in CTLL2 cells

Zdena Tuhácková1, Eva Sloncová, Martina Vojtechová

  • 1Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, 166 37 Prague 6, Czech Republic. tuhack@img.cas.cz

Insights

Interleukin 2 (IL2) stimulates cytolytic T cells by activating the phosphoinositide-3 kinase (PI-3K)/Akt pathway, which influences the mTOR pathway to phosphorylate ribosomal protein S6.

Area of Science:

  • Cellular Biology
  • Molecular Biology
  • Immunology

Background:

  • Growth factors and hormones regulate protein translation via phosphorylation.
  • p70 S6 kinase activation involves PI-3K and mTOR signaling pathways.

Purpose of the Study:

  • To investigate the role of PI-3K and mTOR in IL2-mediated S6 protein phosphorylation in CTLL2 cells.
  • To elucidate the signaling cascade involving Akt in IL2-stimulated T cells.

Main Methods:

  • Stimulation of CTLL2 cells with IL2.
  • Analysis of p70 S6 kinase and ribosomal protein S6 phosphorylation.
  • Treatment with rapamycin and wortmannin to inhibit mTOR and PI-3K pathways, respectively.
  • Assessment of PKB/Akt phosphorylation and activity.

Main Results:

  • IL2 significantly increased S6 and p70 S6K phosphorylation in CTLL2 cells.
  • Rapamycin blocked p70 S6K activity and S6 phosphorylation.
  • Wortmannin decreased S6 phosphorylation and Akt activity, indicating PI-3K involvement.
  • Akt phosphorylation was rapamycin-insensitive but wortmannin-sensitive.

Conclusions:

  • IL2-induced S6 phosphorylation in CTLL2 cells is mediated by a pathway involving PI-3K, Akt, and mTOR.
  • Akt acts downstream of PI-3K and upstream of mTOR in this IL2 signaling pathway.
  • This pathway is crucial for regulating ribosomal protein S6 phosphorylation in response to IL2.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...